Clinical Trials
63 trialsEfficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC
The Central Hospital of Lishui City
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
VICTORIA
Centre Leon Berard
Efficacy and Safety of TORS for SCCA
University of Virginia
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
SELECT-2
Hangzhou Normal University
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
DUNCAN
Philogen S.p.A.
A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Shanghai Henlius Biotech
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
PRINCESS
Fondazione del Piemonte per l'Oncologia
A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions
Synermore Biologics Co., Ltd.
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
Home Management of Simple Hydromorphone PCA Pump Mode
The First Affiliated Hospital of Xinxiang Medical College
HPVOropharynx
Trans Tasman Radiation Oncology Group
Itraconazole in Advanced Ovarian Cancer
Tanta University
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Fudan University
PEN-866 in Patients With Advanced Solid Malignancies
Tarveda Therapeutics
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
Sichuan University
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)
Second Affiliated Hospital of Soochow University
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
Peking University
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
TIDE-A
Consorzio Oncotech
CUDI-RCC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
AVANIRA3
Jiangsu Cancer Institute & Hospital
ANLOLA
Jiangsu Cancer Institute & Hospital
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
MultiVir, Inc.
Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)
Shanghai Chest Hospital
MMIPC
Radboud University Medical Center
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Evolve Biologics
Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Guangzhou Medical University
Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma
Sinocelltech Ltd.
Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC
First Hospital of Shijiazhuang City
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative
First Hospital of Shijiazhuang City
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
LINNEARRE-I
Juravinski Cancer Center
Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line
Cairo University
A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours
Jiangsu Hansoh Pharmaceutical Co., Ltd.
KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma
Kaplan Medical Center
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Samsung Medical Center
Clinical Trials of CT-guided Percutaneous Irreversible Electroporation(IRE)in the Treatment of Patients With Locally Advanced Tumors
Chinese PLA General Hospital
Radiofrequency Ablation of Malignant Pulmonary Nodules
Chinese PLA General Hospital
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Hanmi Pharmaceutical Company Limited
DILIGENCE-1
Auckland District Health Board